Literature DB >> 15128834

Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10.

Alla Skapenko1, Gerald U Niedobitek, Joachim R Kalden, Peter E Lipsky, Hendrik Schulze-Koops.   

Abstract

Tissue damage in many human autoimmune diseases is mediated by activated autoantigen-specific Th1 cells. Delineation of the regulatory mechanisms controlling a Th1-biased human immune reaction and its pathologic potential is, therefore, a critical step in the understanding of autoimmune diseases. In this study, we introduce a novel means to investigate human Th1-biased immune responses in vivo. Intraperitoneal injection of human mononuclear cells into immunodeficient mice generates a xenogeneic Th1-biased human immune response characterized by systemic inflammation and leukocytic infiltrates with a granuloma-like architecture in the liver, and the perigastrointestinal and perirenal fatty tissue. Th1 cell activation was dependent on the presence of APCs and could be blocked by cyclosporine. Importantly, neutralization of endogenously produced IL-4 and IL-10 markedly exaggerated the immune response, whereas exogenous IL-4 and IL-10 inhibited systemic Th1 immunity. Thus, the model described in this paper presents a useful means to analyze the regulation of human immune reactions in an in vivo situation. The results suggest that both IL-4 and IL-10 contribute to controlling the development of a human Th1-biased immune reaction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128834     DOI: 10.4049/jimmunol.172.10.6427

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease.

Authors:  C H Nielsen; L Hegedüs; K Rieneck; A C Moeller; R G Q Leslie; K Bendtzen
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 2.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

Review 3.  Spectrum of T-lymphocyte activities regulating allergic lung inflammation.

Authors:  Erwin W Gelfand; Anthony Joetham; Meiqin Wang; Katsuyuki Takeda; Michaela Schedel
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

4.  Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease.

Authors:  Subir Kumar Das; V Balakrishnan
Journal:  Indian J Clin Biochem       Date:  2011-04-07

Review 5.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

Review 6.  The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

Authors:  Sergio Romagnani
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

7.  The self-antigen, thyroglobulin, induces antigen-experienced CD4+ T cells from healthy donors to proliferate and promote production of the regulatory cytokine, interleukin-10, by monocytes.

Authors:  Claus H Nielsen; Marcel P Galdiers; Chris J Hedegaard; R Graham Q Leslie
Journal:  Immunology       Date:  2009-10-21       Impact factor: 7.397

8.  Immunomodulatory effects of an enzymatic extract from Ecklonia cava on murine splenocytes.

Authors:  Ginnae Ahn; Insun Hwang; Eunjin Park; Jinhe Kim; You-Jin Jeon; Jehee Lee; Jae Woo Park; Youngheun Jee
Journal:  Mar Biotechnol (NY)       Date:  2008-01-03       Impact factor: 3.619

9.  1,25-dihydroxyvitamin D(3) regulates LPS-induced cytokine production and reduces mortality in rats.

Authors:  Xiao-Ping Qi; Pei Li; Gang Li; Zhen Sun; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

10.  Oral administration of PPC enhances antigen-specific CD8+ T cell responses while reducing IgE levels in sensitized mice.

Authors:  Mike Burrows; Deepak Assundani; Esteban Celis; Frank Tufaro; Akiko Tanaka; W Guy Bradley
Journal:  BMC Complement Altern Med       Date:  2009-11-30       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.